漢田生技 (1294.TW) 2025Q2 shows a mild decline in contract liabilities year-on-year. This slight decrease in new orders may be caused by delivery postponements, early revenue recognition, or shifts in external demand. Continued observation of new order momentum and industry conditions in coming quarters is recommended.